Sinofn Adopts Liposomal Technology to Enhance Nutrient Absorption

Sinofn (Tianjin) Pharm-Tech Co., Ltd., a company specializing in pharmaceutical technology, has adopted liposomal delivery systems to enhance the bioavailability of nutritional supplements. This approach utilizes microscopic vesicles made of phospholipids, structurally similar to human cell membranes, to encapsulate active ingredients.

The primary goal of this technological integration is to address significant issues in supplement formulation, such as the poor absorption and degradation of nutrients like curcumin, CoQ10, and various botanical antioxidants within the digestive system. These conventional limitations can reduce the effectiveness of even high-quality raw materials.

Sinofn's liposomal systems, typically ranging from 50 to 200 nanometers, are designed for improved interaction with intestinal cells, leading to a higher rate of nutrient absorption. The company, through its Sinofn Health division, offers these systems across various product formats, including liquid supplements, encapsulated powders, and functional beverage systems.

In addition to its standard offerings, Sinofn provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services. This allows other brands to leverage Sinofn's advanced liposomal formulation capabilities to develop customized nutritional products tailored to specific market needs and consumer demands.